Portfolio company
Cellino
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellino Bio
This company develops an autonomous biomanufacturing platform that uses artificial intelligence and lasers to produce personalised cell therapies for patients with degenerative diseases.
Cellular Origins
The company develops an automated robotic platform for cell therapy developers to manufacture and scale autologous and allogeneic therapies.
Sarcura
This company develops automated platforms for large-scale manufacturing of personalised cell therapies for the biopharmaceutical industry.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Eyestem
The company develops cell replacement therapies to treat incurable blindness and retinal diseases for patients globally.
Cellvoyant
Cellvoyant develops AI-powered imaging platforms and services to predict and optimise stem cell differentiation for biotechnology and pharmaceutical organisations developing cell-based therapies.
Stately Bio
This company develops machine learning imaging platforms and stem cell-derived therapies for biopharmaceutical researchers and clinical institutions.
